Literature DB >> 33586256

Synthesis and in vitro study of antiproliferative benzyloxy dihydropyrimidinones.

Ruturajsinh M Vala1, Mayank G Sharma1, Divyang M Patel1, Adrián Puerta2, José M Padrón2, Venkatachalam Ramkumar3, Ramesh L Gardas3, Hitendra M Patel1.   

Abstract

In this study, we report on antiproliferative benzyloxy dihydropyrimidinones (DHPMs) produced by the Biginelli reaction of benzyloxy benzaldehyde, urea, and diverse 1,3-diones. The reaction was catalyzed by lanthanum triflate and completed within 1-1.5 h, with 74-97% yield. The antiproliferative assay was carried out for all synthesized dihydropyrimidinones against six human solid tumor cell lines. Six compounds showed good antiproliferative activity with GI50 values below 5 μM. Among all the synthesized compounds, the most potent derivative showed good antiproliferative activity against all cell lines with GI50 values in the range of 1.1-3.1 μM. These DHPMs comply with druglikeness. Furthermore, ADMET prediction and the effect of P-glycoprotein on the antiproliferative activity were also studied. Overall, our method allows eco-friendly access to benzyloxy DHPMs as potential anticancer drugs.
© 2021 Deutsche Pharmazeutische Gesellschaft.

Entities:  

Keywords:  Lipinski's rule of five; antiproliferative activity; dihydropyrimidinones; lanthanum triflate

Mesh:

Substances:

Year:  2021        PMID: 33586256     DOI: 10.1002/ardp.202000466

Source DB:  PubMed          Journal:  Arch Pharm (Weinheim)        ISSN: 0365-6233            Impact factor:   3.751


  2 in total

1.  One-pot two-step catalytic synthesis of 6-amino-2-pyridone-3,5-dicarbonitriles enabling anti-cancer bioactivity.

Authors:  Lynden G Nicely; Ruturajsinh M Vala; Dipti B Upadhyay; Joaquina Nogales; Celestine Chi; Sourav Banerjee; Hitendra M Patel
Journal:  RSC Adv       Date:  2022-08-24       Impact factor: 4.036

2.  Synthesis, crystal structure and in silico studies of novel 2,4-dimethoxy-tetrahydropyrimido[4,5-b]quinolin-6(7H)-ones.

Authors:  Subham G Patel; Ruturajsinh M Vala; Paras J Patel; Dipti B Upadhyay; V Ramkumar; Ramesh L Gardas; Hitendra M Patel
Journal:  RSC Adv       Date:  2022-06-29       Impact factor: 4.036

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.